Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
5
×
biotech
eli lilly
5
×
life sciences
5
×
merck
5
×
national
national blog main
national top stories
new york blog main
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
deals
europe blog main
fda
moderna
allergan
amgen
What
bio
roundup
companies
drug
approved
debut
fda
moves
nash
new
news
treatment
week
acquisitions
adults
allergan
approval
biggest
biogen’s
biopharmaceutical
black
build
buy
ceo
class
company’s
continue
convo
daniel
diamond
diamond’s
digital
disease
dyne’s
earlier
epidemic
failures
fatty
frenzied
gilead
Language
unset
Current search:
merck
×
abbvie
×
" life sciences "
×
" eli lilly "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More